SBC-115337
CAS No. 423148-46-3
SBC-115337( —— )
Catalog No. M24388 CAS No. 423148-46-3
SBC-115337 is a PCSK9 inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 222 | In Stock |
|
10MG | 357 | In Stock |
|
25MG | 597 | In Stock |
|
50MG | 851 | In Stock |
|
100MG | 1152 | In Stock |
|
500MG | 2313 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSBC-115337
-
NoteResearch use only, not for human use.
-
Brief DescriptionSBC-115337 is a PCSK9 inhibitor.
-
DescriptionSBC-115337 is a PCSK9 inhibitor.
-
In VitroThe potent compound (SBC-115,337) shows an IC50 of 0.6 μM measured in an in vitro ELISA assay to monitor the effect of PCSK9 binding to the recombinant LDLR. SBC-115,337 at 1.2 μM induces more than tenfold upregulation of LDLR in HepG2 cells with respect to the control, increases uptake of fluorescently labeled DiI-LDL and loweres LDL-c levels in mice fed a high-fat diet.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorPSCK9
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number423148-46-3
-
Formula Weight473.48
-
Molecular FormulaC29H19N3O4
-
Purity>98% (HPLC)
-
SolubilityDMSO: 6mg/mL?(12.67mM;ultrasonic and warming and heat to 60℃)
-
SMILESO=C(C1=CC2=CC=CC=C2O1)NC3=CC=C(C(NC4=CC=C(C5=NC6=CC=CC=C6O5)C=C4)=O)C=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Lavecchia A , Cerchia C . Recent advances in developing PCSK9 inhibitors for lipid-lowering therapy[J]. Future medicinal chemistry, 2019, 11(5):423-441.
molnova catalog
related products
-
Nerol
Nerol is a monoterpene found in many essential oils such as lemon balm and hop.Nerol can lessened the severity of ouabain-triggered arrhythmias in mammalian heart.
-
Isorhapontin
Isorhapontin inhibits the activity of Trichoderma cellobiohydrolase I (Ki = 57.2 μM) and Trichoderma endoglucanase I. Isorhapontin shows antifungal activity.
-
KIRA6
KIRA6 is an effective inhibitor of IRE1α RNase kinase (IC50: 0.6 μM). It can trigger an apoptotic response.KIRA6 (10-1000 nM, 72 hours) strongly compromises the viability of the KIT-dependent cell line HMC-1.1 at the low nM concentration, in a manner that coincided with KIT blockade.